Last reviewed · How we verify
Topical application of a fluorescent imaging agent — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Topical application of a fluorescent imaging agent (Topical application of a fluorescent imaging agent) — Erasmus Medical Center.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Topical application of a fluorescent imaging agent TARGET | Topical application of a fluorescent imaging agent | Erasmus Medical Center | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Topical application of a fluorescent imaging agent CI watch — RSS
- Topical application of a fluorescent imaging agent CI watch — Atom
- Topical application of a fluorescent imaging agent CI watch — JSON
- Topical application of a fluorescent imaging agent alone — RSS
Cite this brief
Drug Landscape (2026). Topical application of a fluorescent imaging agent — Competitive Intelligence Brief. https://druglandscape.com/ci/topical-application-of-a-fluorescent-imaging-agent. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab